Competing treatments for migraine: a headache for decision-makers
{{output}}
Background: Migraine is the world's second most common disabling disorder, affecting 15% of UK adults and costing the UK over £1.5 billion per year. Several costly new drugs have been approved by National Institute for Health an... ...